Evidence map›Paper›PMID 22132215›Full record

ArticlePloS one2011

The role of the novel exopolyphosphatase MT0516 in Mycobacterium tuberculosis drug tolerance and persistence.

Seema M Thayil, Norman Morrison, Norman Schechter, Harvey Rubin, Petros C Karakousis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Gallein and isoniazid act synergistically to attenuatebioRxiv : the preprint server for biology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Phenotypic adaptation ofFrontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Targeting theFrontiers in microbiology · 2021
    Review
  10. Polyphosphate is an extracellular signal that can facilitate bacterial survival in eukaryotic cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Potential therapeutic approaches for a sleeping pathogen: tuberculosis a case for bioinorganic chemistry.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Review
  12. Frontiers in microbiology · 2020
    Article
  13. Article
  14. Mechanisms of Antibiotic Tolerance inFrontiers in microbiology · 2020
    Review
  15. Review
  16. Phase variation inProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. Article
  18. Article
  19. Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Seema M ThayilDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Norman Morrison
Norman Schechter
Harvey Rubin
Petros C Karakousis
Johns Hopkins Medicine · USUniversity of Pennsylvania · USJohns Hopkins University · US

Funding

A Multidisciplinary Approach to Understanding TB Latency and ReactivationR01HL106786 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BADER, JOEL S., KARAKOUSIS, PETROS C · 2010 to 2013
$3.1M
Regulatory networks involved in Mycobacterium tuberculosis persistenceR01AI083125 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KARAKOUSIS, PETROS C · 2009 to 2013
$2.7M
Modeling latent TB InfectionK08AI064229 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KARAKOUSIS, PETROS C · 2005 to 2009
$679k
NHLBI NIH HHS R01 HL106786NHLBI NIH HHS R01HL106786NIAID NIH HHS K08 AI064229NIAID NIH HHS K08AI064229NIAID NIH HHS R01 AI083125NIAID NIH HHS R01AI083125
6 · The paper itself

Abstract

Inorganic polyphosphate (poly P) has been postulated to play a regulatory role in the transition to bacterial persistence. In bacteria, poly P balance in the cell is maintained by the hydrolysis activity of the exopolyphosphatase PPX. However, the Mycobacterium tuberculosis PPX has not been characterized previously. Here we show that recombinant MT0516 hydrolyzes poly P, and an MT0516-deficient M. tuberculosis mutant exhibits elevated intracellular levels of poly P and increased expression of the genes mprB, sigE, and rel relative to the isogenic wild-type strain, indicating poly P-mediated signaling. Deficiency of MT0516 resulted in decelerated growth during logarithmic-phase in axenic cultures, and tolerance to the cell wall-active drug isoniazid. The MT0516-deficient mutant showed a significant survival defect in activated human macrophages and reduced persistence in the lungs of guinea pigs. We conclude that exopolyphosphatase is required for long-term survival of M. tuberculosis in necrotic lung lesions.

Indexed as

Acid Anhydride HydrolasesAnimalsAnti-Bacterial AgentsBacterial ProteinsDNA Transposable ElementsDrug Resistance, BacterialFemaleGenetic Complementation TestGuinea PigsHumansHydrolysisIsoniazidLungModels, MolecularMutationMycobacterium tuberculosisAcid Anhydride HydrolasesAnti-Bacterial AgentsBacterial ProteinsDNA Transposable ElementsexopolyphosphataseIsoniazidPolyphosphates

Identifiers

PMID22132215
PMCPMC3221697
OpenAlexW2028021108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.